Certainly, in order to find more precise targets for obesity treatment, further studies are required to elucidate the specific mechanism by which SPRY4 activates the ERK1/2 signalling pathway. This evidence concerns the gene SPRY4 and obesity due to melanocortin 4 receptor deficiency.